Cannabis Law Report

JULY 27, 2021

.–(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has appointed Nicolas Schlienz, Ph.D., as its Research Director, a new role in the organization’s leadership. RoC is committed to research into novel healthcare options to improve quality of life. About Realm of Caring.

Data 81

Data Epilepsy Research and Development Clinical Trials 81

Veriheal

JUNE 22, 2020

Whether or not cannabis use during pregnancy causes physical, cognitive, or mental impairments later in life has been something scientists and researchers have been investigating for decades. Unfortunately, much of the research conducted thus far have not shown the whole picture or clinical implications for children in real life.

Research and Development 98

Research and Development Data Policy Education 98

Cannabis Law Report

AUGUST 1, 2021

Unfortunately, on the negative side, Connecticut yet again extended the 10% surcharge on the corporation business tax, and delayed and extended the phase-out of the capital base tax on corporations.

Research and Development 105

Research and Development Programs Legislation Business 105

The Cannigma

OCTOBER 22, 2023

The Cannigma has always taken a data-informed approach to content creation – though up until recently we’ve been primarily leaning on the existing peer-reviewed literature to guide our content. We need more data – human data – on specific applications for the plant – symptoms, use cases, conditions and patient types.

Data 88

Data Research and Development Sleep Collective 88

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.

Research and Development 108

Research and Development Data THC Clinical Trials 108

The Cannigma

NOVEMBER 12, 2023

The combination of minor cannabinoids THCV and CBG could help reduce bad eating habits like snacking and late-night binge eating, according to real-world data (RWD) collected from Cannigma readers last month. But the decrease in appetite is not just seen in the data – it’s also part of the lived experience.

Data 105

Data Tincture Research and Development Food 105

Project CBD

JANUARY 24, 2019

Their data suggests that ADHD causes later cannabis use, which may support the notion that THC is used to self medicate (although ADHD is associated with heavier use of many drugs). Previous research has found that THC may be effective for some cases that do not respond well to Ritalin. . Cannabinoid crystals.

Research and Development 256

Research and Development Chronic Pain Cannabinoids Treatment 256

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 179

CBD Blood Pressure Research and Development Cannabinoids 179

Cannabis Law Report

APRIL 28, 2021

Poster presentation to address the preclinical cannabidiol derivative for the potential treatment of psychiatric disorders BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. Nasdaq:… Read More.

Pharmaceutical 98

Pharmaceutical Data Medicine Treatment 98

Cannabis Law Report

JUNE 4, 2021

Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021. The post AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591 appeared first on CannabisFN. Phase 2 trial underway.

Data 100

Data Research and Development Clinical Trials Therapy 100

The Cannigma

JANUARY 16, 2021

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. So Releaf app is an app that we released back in 2016.

Data 100

Data Research and Development Patients Strains 100

Veriheal

SEPTEMBER 14, 2021

The findings of a new study into cannabis use disorder (CUD) among veterans have been released by a team of researchers from Pennsylvania’s Center of Excellence in Substance Addiction Treatment and Education at the Corporal Michael J. Crescenz VA Medical Center. Their hypothesis was published in the American Journal of Psychiatry.

Consumption 98

Consumption Research and Development Treatment Programs 98

Veriheal

NOVEMBER 30, 2021

Veriheal does not support illegally consuming therapeutic substances such as psilocybin but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies.

Research and Development 98

Research and Development Therapy Data Treatment 98

Cannabis Law Report

DECEMBER 27, 2019

Clinical trials are medical research projects involving human participants. However, the costs of conducting a full-scale clinical trial can be prohibitive, posing barriers to research for cannabis companies. Cognizance VCT enables the generation of cost-effective quality data with ethical consent, on par with academic studies.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Cannabis Law Report

JULY 8, 2021

(NYSE American: YCBD, YCBDpA), one of the leading, and most highly trusted and recognized CBD companies, announced today that its recently formed division, cbdMD Therapeutics, has initiated talks with one of the leading US cannabinoid research institutes, to identify novel cannabinoids for therapeutic use. About cbdMD, Inc. cbdMD, Inc.

Research and Development 85

Research and Development Pets Cannabinoids Clinical Trials 85

Veriheal

FEBRUARY 19, 2021

The lack of research is one of the many reasons that cannabis remains federally illegal. But one of the barriers to conducting the necessary research is its federally illegal status. These intertwining factors plaguing cannabis research must be eradicated for the sake of medical cannabis consumers. .

Legalization 94

Legalization Research and Development Safety Data 94

Veriheal

JANUARY 31, 2023

Researchers Reach a Moral Conundrum According to Vikiana Clement, the former executive director of the Cannabis Education Task Force at Brooklyn’s Medgar Evers College and the researcher, purchasing cannabis from the illicit market may be the “true moral choice” depending on circumstances. This is a data analysis.”

Legalization 105

Legalization Research and Development Business Cannabis 105

Veriheal

NOVEMBER 13, 2020

Until recently, there has been little to no research available that examines the effects of cannabis in patients diagnosed with Obsessive-Compulsive Disorder (OCD). Thanks to an ever increasing interest in the medical benefits of cannabis, a study was recently conducted that researched the acute effects of cannabis on the symptoms of OCD.

Research and Development 98

Research and Development Consumption Patients Strains 98

Cannabis Law Report

JULY 7, 2021

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. MYMD-1 is being developed to treat autoimmune and age-related diseases, and to slow aging thereby increasing life-span. Acumen Research and Consulting confirmed TNF-? President, Director and Chief Medical Officer of MyMD.

Pharmaceutical 81

Pharmaceutical Data Clinical Trials Research and Development 81

Cannabis Law Report

JULY 29, 2021

Scientists and researchers do not know exactly how or why these negative results occur, but they are still working on the question. Our main product is the Ehave Telemetry Portal, which is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insights. Gabe@Ehave.com.

Research and Development 81

Research and Development Conditions Data Patients 81

The Cannigma

APRIL 6, 2021

Such limits are not backed by scientific research and should be scrapped, concluded the panel of experts led by the California Highway Patrol. A per se limit for drugs, other than ethanol, should not be enacted at this time as current scientific research does not support it. Drugs affect people differently depending on many variables.

THC 139

THC Research and Development Collective Concentrates 139

Cannabis Law Report

JULY 19, 2021

The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. billion by 2027.

Therapy 76

Therapy Data Research and Development Events 76

The Cannigma

JUNE 14, 2021

For more than 50 years, if you wanted to do cannabis research in the United States, federal law said you had to get the cannabis from the University of Mississippi. We are absolutely ecstatic,” George Hodgin, the CEO of the Castroville, California based Biopharmaceutical Research Co. BRC) told The Cannigma this week.

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

Cannabis Law Report

AUGUST 3, 2021

(CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. Using machine learning algorithms and qualified practitioner input, the company is leveraging that data to build tools that deliver digital diagnostic opinions.

Research and Development 105

Research and Development Data Conditions Therapy 105

Cannabis Law Report

AUGUST 30, 2021

.–(BUSINESS WIRE)– #cannabis — Dewey Scientific , an agtech innovator pioneering solutions for a sustainable and thriving cannabis industry, announced today the online publication of new data describing the first experimentally validated disease resistance gene in cannabis. Garfinkel, PhD.

Research and Development 79

Research and Development Sativa Agriculture Cultivation 79

NewsMunchies

JULY 10, 2023

Artificial intelligence is a smarter, faster, and more effective pathway to drug development. With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds major potential to increase the accessibility of drugs and to treat diseases and conditions.

Treatment 58

Treatment Research and Development Pharmaceutical Microdosing 58

Veriheal

JUNE 27, 2023

After over four years of observation, the researchers found no traces of Chronic Obstructive Pulmonary Disease (COPD) —a condition commonly associated with tobacco smoking, characterized by coughing and shortness of breath—whether in developmental or advanced stages.

Research and Development 105

Research and Development Data Collective Vaping 105

Cannabis Law Report

SEPTEMBER 9, 2021

WHAT: During the session, “ Cannabis Moves Toward the Mainstream ,” Nielsen will share IRI and BDSA’s predictions for mainstream market opportunities, cannabis ingredients, product development, labeling and safety. . . WHEN: Cross Channel Measurement in a Time of Data Collection Challenges. . Pivoting on New Product Development. .

Events 78

Events Wellness and Beauty Data Media 78

Cannabis Law Report

JUNE 5, 2021

On Wednesday, Argentina’s Minister of Productive Development, Matías Kulfas , presented a bill titled, “Regulatory framework for the development of the medical cannabis and hemp industry ,” within the framework of the Economic and Social Council. Supplier development: Genetics, agro 4.0, Yahoo Finance reports.

Hemp 105

Hemp Research and Development Pharmaceutical Agriculture 105

FloridaMarijuana.net

SEPTEMBER 24, 2018

These essential oils are called Terpenes, and while research is still evolving, science has proven that these oils can drastically improve a patient’s quality of life. Even drugstores, grocery stores and everywhere in between carry variations of plant essential oils and products containing oils to improve health.

Terpenes 162

Terpenes Oil Strains Research and Development 162

Veriheal

DECEMBER 9, 2021

Opponents are likely referencing studies that link mental illness to regular cannabis use, even though those studies have been invalidated by research and do not even revolve around legalization. The team also suggests that legalization at federal levels will allow for more comprehensive research and results. Singer et al.

Legalization 98

Legalization Research and Development Consumption Recreational 98

Cannabis Law Report

JUNE 29, 2021

Desai brings to Ehave the ability to visualize opportunities and execute creative strategic solutions, while developing deep networks and relationships within the industry. Research in the area of mental health has been Dr. Nitin Desai’s passion. Ben Kaplan, CEO of Ehave, Inc. Forward-Looking Statement Disclaimer.

Clinical Trials 105

Clinical Trials Research and Development Data Patients 105

Cannabis Law Report

FEBRUARY 10, 2022

~Gary Allen, CEO, New Frontier Data. Our latest report, 22 for 2022: Cannabis Industry Assertions & Predictions, provides a data-centric blueprint for navigating near-term challenges and positioning for new opportunities in a burgeoning industry.

Data 52

Data Research and Development Hemp Legalization 52

Project CBD

MARCH 29, 2023

Recent research — including papers co-authored by Mechoulam well into his 80s — has confirmed that aberrant CB2 signaling is implicated in a raft of autoimmune, neurodegenerative, metabolic, and psychiatric disorders. CB2 is also an increasingly hot topic in cancer research.

Research and Development 159

Research and Development Cannabinoids CBD THC 159

Veriheal

FEBRUARY 9, 2023

Now, Australian researchers think they may have found an answer: taking psilocybin before MRIs. While comfy MRIs are not its primary goal, this psychedelic research has provided solid preliminary evidence that the psychoactive compound found in magic mushrooms can help accomplish just that.

Clinical Trials 98

Clinical Trials Research and Development Data Collective 98

Medicinal Marijuana Association

FEBRUARY 10, 2024

With over 100 known cannabinoids in cannabis, staying informed about the latest research is crucial for making informed decisions. Understanding how to discern reliable sources, interpret research methodologies, and apply key findings to real-world scenarios can be daunting.

Research and Development 52

Research and Development Data Chronic Pain Conditions 52

Veriheal

MAY 3, 2022

A recent study , funded by the National Institute on Drug Abuse (NIDA) and published in JAMA Network Open , reported a correlation between obtaining a medical marijuana (MMJ) card and developing CUD. Despite being published in a reputable journal, there are questions about the legitimacy of the research.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98